The Biodesign Institute

Starlight Cardiovascular Appoints Paul G. Yock, MD to its Board of Directors

Retrieved on: 
Tuesday, June 13, 2023
Rapid Exchange of Information System, Ventricular septal defect, Technology education, The Biodesign Institute, Stanford University, University of Washington Department of Bioengineering, IVUS, Congenital heart defect, National academy, Stanford University School of Medicine, Standard of care, SAN, Birth defect, Biological engineering, National Academy of Engineering of Korea, Entrepreneurship, CHD, Pharmaceutical industry, Engineering, Medicine

SAN DIEGO, June 13, 2023 /PRNewswire/ -- Paul G. Yock has joined the Starlight Cardiovascular Board of Directors. Dr. Yock is the Founder, Director Emeritus, and a Board Member of the Stanford Byers Center for Biodesign. He is the former Martha Meier Weiland Professor of Medicine, founding co-chair of Stanford University's Department of Bioengineering, and the 2018 recipient of the National Academy of Engineering's Gordon Prize for Innovation in Engineering and Technology Education. Yock, who is trained as an interventional cardiologist, is known for his numerous innovative contributions to medical technology, including the Rapid Exchange angioplasty and stenting system, intravascular ultrasound (IVUS), and the Smart Needle.

Key Points: 
  • SAN DIEGO, June 13, 2023 /PRNewswire/ -- Paul G. Yock has joined the Starlight Cardiovascular Board of Directors.
  • "We are overjoyed that Paul has joined the Starlight family," stated Beverly Tang, co-Founder and CEO of Starlight Cardiovascular.
  • Yock was appointed as an independent director and joins Alf Grunwald, Tom Duerig, and Beverly Tang on the Board of Directors.
  • "Starlight Cardiovascular is taking on this challenge by developing highly novel pediatric technologies -- and, equally important, pioneering novel approaches to business execution.

Sun Genomics Appoints Vice President of Sales and Business Development

Retrieved on: 
Tuesday, May 16, 2023
Partnership, American Academy of Anti-Aging Medicine, Arizona State University, Spectrum, Genomics, The Biodesign Institute, Synbiotics, Quality of life, American Academy, Research, A4M, Patient, ASD, SAN, Happiness, Fonterra, Knowledge, Yung Bleu, Health, Probiotic, Mental health, Pharmaceutical industry

SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) -- Sun Genomics, a leader in gut health testing that specializes in made-to-order probiotics based on an individual’s gut microflora, continues to strategically expand its brand and clinical offerings with the appointment of Will Hankee as vice president of sales and business development.

Key Points: 
  • SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) -- Sun Genomics, a leader in gut health testing that specializes in made-to-order probiotics based on an individual’s gut microflora, continues to strategically expand its brand and clinical offerings with the appointment of Will Hankee as vice president of sales and business development.
  • There, he grew the organization’s clinical presence of diagnostic testing on a global scale and has a proven sales leadership background focused on developing high-performing technical sales teams.
  • Sun Genomics will also exhibit at A4M The Fire Inside , taking place from May 18-20 in Orlando, FL.
  • For more information on Sun Genomics or Floré, the world’s only fully customized probiotic, visit www.flore.com .

Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign

Retrieved on: 
Monday, March 20, 2023
Science, Biotechnology, Research, General Health, Health, Health Technology, University, Education, Senior, Engineering, The Biodesign Institute, Stanford University, EVP, Policy, Connected, PST, Stanford University School of Medicine, Student, LSI, Faculty, Biological engineering, Digital, Ecosystem, Management, Medicine

Veranex , the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for Biodesign .

Key Points: 
  • Veranex , the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for Biodesign .
  • Stanford Biodesign trains and supports students, fellows, faculty, and global executives in healthcare technology innovation.
  • Veranex is the first medtech innovation solutions firm to sponsor the program.
  • “We’re honored to join industry leaders in supporting Stanford Biodesign because we share their commitment to innovation education and achieving the extraordinary,” said Pat Donnelly, Chairman and CEO of Veranex.

A new start: Learn, Grow and Thrive at iBHE, Tsinghua SIGS

Retrieved on: 
Monday, November 28, 2022
Engineering, Conference, City, Student, Knowledge, Bernard Dadié national grand prize for literature, IBH, European Master Program in Computational Logic, Biopharmaceutical, Biological engineering, Exhibition, Tsinghua University, Translational medicine, Health, Research, The Biodesign Institute, Science, Prize, James Dyson, Biology, Mentorship, Management

Her research works have also been exhibited in Triennale Milano, New York Design Week, World Design Cities Conference and many other international exhibitions.

Key Points: 
  • Her research works have also been exhibited in Triennale Milano, New York Design Week, World Design Cities Conference and many other international exhibitions.
  • She said when she dedicates herself to the issues on human health and sustainable development, she always gain a tremendous sense of self-value.
  • To achieve her strong cross-disciplinary research interest at the intersection of biology, engineering and design, she chose to start her future study at iBHE, Tsinghua SIGS.
  • Talking about her studying experience at iBHE, she said, "Tsinghua SIGS provides an open and inclusive academic exchange platform and rich opportunities for industry-academia-research cooperation for interdisciplinary students like her.

Tarsus Announces Transition Plans for Board of Directors

Retrieved on: 
Tuesday, October 11, 2022
The Biodesign Institute, U.S. Securities and Exchange Commission, Infection, SEC, Growth, Science, Dermatology, New Drug Application, NASDAQ, Patient, Director, Lead, Security (finance), Technology, Company, Salivary gland disease, Board, CEO, GLOBE, Board of directors, Lyme disease, FDA, TARS, Risk, Leadership, Management, Pharmaceutical industry, Biotechnology

IRVINE, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to address patient needs, starting with eye care, through the application of proven science and new technology, today announced several expected upcoming transitions to its Board of Directors by year-end. Tarsus Co-Founder and Chairman, Michael Ackermann, Ph.D., plans to transition off the Board of Directors. Upon Dr. Ackermann’s planned transition, Wendy Yarno, industry veteran and current member of the Board, will be appointed Lead Independent Director, and CEO Bobak Azamian, M.D., Ph.D., will assume the role of Chairman.

Key Points: 
  • Tarsus Co-Founder and Chairman, Michael Ackermann, Ph.D., plans to transition off the Board of Directors.
  • Upon Dr. Ackermanns planned transition, Wendy Yarno, industry veteran and current member of the Board, will be appointed Lead Independent Director, and CEO Bobak Azamian, M.D., Ph.D., will assume the role of Chairman.
  • I am forever grateful to Bobby and the rest of the Tarsus leadership team for making the original vision for the Company a reality.
  • These statements include statements regarding the expected Board transition, Tarsus plans for and the anticipated benefits of its product candidates including TP-03 and TP-05, the benefits and value added by the planned director transition, the timing, objectives and results of the clinical trials, anticipated regulatory and development milestones, and the quotations of Tarsus management and board members.

Catalyst Connect Recognized in Inc. 5000 List of Fastest Growing Private Companies

Retrieved on: 
Wednesday, August 31, 2022
University, Stanford University centers and institutes, Technology, Eller College of Management, Ace Hardware, Associate, Microsoft, 320th Troop Carrier Squadron, The Biodesign Institute, Solution, J.D. Power, Chobani, Organization, Catalysis, Multimedia, Inc., Zoho Corporation, Center, Stanford University, Facebook, University of Arizona College of Optical Sciences, Name, Growth, Environment, Skyline, Telecommunication, Online shopping

TUCSON, Ariz., Aug. 31, 2022 /PRNewswire/ -- This month Inc. revealed that Catalyst Connect  is No. 2388 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. Catalyst Connect specializes in implementing Zoho software to streamline client engagement and operations. The list represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segment—its independent businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

Key Points: 
  • Catalyst Connect ranked 320th fastest growing software small business in United States, reported growth of 244% by Inc. 5000's annual list for 2022
    Catalyst Connect ranked 320th fastest growing software small business in United States, reported growth of 244% by Inc.
    TUCSON, Ariz., Aug. 31, 2022 /PRNewswire/ -- This month Inc. revealed that Catalyst Connect is No.
  • 2388 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America.
  • Catalyst Connect specializes in implementing Zoho software to streamline client engagement and operations.
  • The list represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segmentits independent businesses.

Catalyst Connect Recognized in Inc. 5000 List of Fastest Growing Private Companies

Retrieved on: 
Wednesday, August 31, 2022
University, Stanford University centers and institutes, CEO, Technology, Eller College of Management, Ace Hardware, Associate, Microsoft, 320th Troop Carrier Squadron, The Biodesign Institute, Business operations, Solution, J.D. Power, Chobani, Organization, Catalysis, Multimedia, Inc., Zoho Corporation, Center, Stanford University, Facebook, University of Arizona College of Applied Science and Technology, Name, Growth, Environment, Skyline, Telecommunication, Online shopping

TUCSON, Ariz., Aug. 31, 2022 /PRNewswire/ -- This month Inc. revealed that Catalyst Connect  is No. 2388 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. Catalyst Connect specializes in implementing Zoho software to streamline client engagement and operations. The list represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segment—its independent businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

Key Points: 
  • Catalyst Connect ranked 320th fastest growing software small business in United States, reported growth of 244% by Inc. 5000's annual list for 2022
    Catalyst Connect ranked 320th fastest growing software small business in United States, reported growth of 244% by Inc.
    TUCSON, Ariz., Aug. 31, 2022 /PRNewswire/ -- This month Inc. revealed that Catalyst Connect is No.
  • 2388 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America.
  • Catalyst Connect specializes in implementing Zoho software to streamline client engagement and operations.
  • The list represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segmentits independent businesses.

MedtechWomen Announces Tenth Annual MedtechVision Conference

Retrieved on: 
Monday, August 29, 2022
Biotechnology, Pharmaceutical, Hardware, General Health, Health, Medical Devices, Health Technology, Technology, Sprig, Associate Director of National Intelligence and Chief Information Officer, Partnership, CEO, Platinum, Reproductive health, Robins Kaplan LLP, ZIO, Medical device, McDermott Will & Emery, Medtech, Venable LLP, Alumni association, Learning, Diagnosis, Gold, Wilson Sonsini Goodrich & Rosati, Partner, The Biodesign Institute, Bolster, Conference, Stanford University, Medtronic, Woman, Johnson & Johnson, Industry, Management, Pharmaceutical industry

MedtechWomen today announced its tenth annual MedtechVision Conference, designed by and for women at the forefront of medical innovation.

Key Points: 
  • MedtechWomen today announced its tenth annual MedtechVision Conference, designed by and for women at the forefront of medical innovation.
  • MedtechVision 2022 will host experts from across the industry for a day of networking, learning and collaboration.
  • We are thrilled to be back in person at an expanded venue with our Stanford Biodesign partners for the 2022 MedtechVision Conference, said Deb Kilpatrick, MedtechWomen co-founder and co-CEO, Evidation Health.
  • As a sponsor of the MedtechVision Conference, Alira Health is publishing a state of the Medtech Industry Report especially for the summit.

PA Consulting congratulates the winners of Stanford Biodesign's Robert Howard Next Step Award

Retrieved on: 
Monday, June 13, 2022
Linda, Digital health, Faculty, Pediatrics, PA Consulting Group, Social skills, Stanford University, Program, Product, Autism spectrum, LinkedIn, Autism, Policy, Government, Engineering, Creativity, The Biodesign Institute, Health, Stanford University School of Medicine, Twitter, MD, Prevalence, Department, MSME, Consultant, Education, University, Medicine, Management, Life

John Edson, US Head of Design and Engineering at PA Consulting, said:"We are in awe of the talent and innovation that all of this year's health tech teams showcased.

Key Points: 
  • John Edson, US Head of Design and Engineering at PA Consulting, said:"We are in awe of the talent and innovation that all of this year's health tech teams showcased.
  • The Robert Howard Next Step Award winners from the Wall Lab at Stanford won over the jury with their aim to create an accessible-for-all solution to help bridge the social skills gap for children with autism.
  • PA began its sponsorship of the Robert Howard Next Step Award in Spring 2022.
  • In 2011, Stanford Biodesign and LUNAR established this memorial award in Robert's name, and this year PA Consulting has taken over its sponsorship.

Calviri Completes Enrollment of 800 Dogs in a Preventative Cancer Vaccine Trial

Retrieved on: 
Tuesday, June 7, 2022
Oncology, Health, Clinical Trials, Pharmaceutical, Biotechnology, Veterinary, ASU, Arizona State University, Research, University of California, Davis, Knowledge, Veterinary medicine, Invention, Open philanthropy (doctrine), DSMB, Ageing, CEO, Veterinarian, RNA, Cancer, COVID-19, Hope, UC, PI, Multimedia, School, University, Vaccine, The Biodesign Institute, Risk, Data monitoring committee, Dog, Colorado State University, Diagnosis, Population, History, Health, Fire, Safety, Pharmaceutical industry, Medical imaging

Phoenix, Arizona, healthcare company Calviri, Inc., has completed full enrollment in the Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.

Key Points: 
  • Phoenix, Arizona, healthcare company Calviri, Inc., has completed full enrollment in the Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.
  • View the full release here: https://www.businesswire.com/news/home/20220607005397/en/
    The double-blinded trial is testing Calviris vaccine aimed at broadly preventing cancers in dogs.
  • This trial has been a great learning experience for developing the improved preventative vaccine that we are currently producing, as well as new therapeutic vaccines we plan.
  • Calviri is focused on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer.